The Analysis of Structural Diversity in the Antibody Response

  • Gillian M. Griffiths
  • Cesar Milstein


The heterogeneity of the antibody response presented a major problem to im-munochemists wishing to study antibody structures. Such studies required large amounts of a single immunoglobulin molecule, which could not be obtained from normal immune sera. The discovery that multiple myelomas were tumors originating from a single clone of antibody-producing cells and hence gave rise to a homogeneous source of immunoglobulin was therefore extremely important and enabled the first structural studies of immunoglobulin molecules to be carried out.1,2 Mouse plasmacytomas were particularly important because they provided homogeneous sources of antibodies that could be passaged and adapted to cell culture.3,4 The use of myelomas provided a vast amount of information concerning immunoglobulin structure.5–7 Myelomas also provided the early material to study the immunoglobulin gene organization of mouse and man. It was clear from these studies that a vast amount of structural diversity can be generated from a finite number of immunoglobulin genes (reviewed in Ref. 8). However, a detailed study of the structural diversity of the antibody response to a defined antigen was not possible, since myelomas do not originate from a response to a defined antigen. The most exciting aspect, namely the change during the maturation of the response, could not be defined at the molecular level.


Antibody Response Heavy Chain Homogeneous Source mRNA Template Nucleic Acid Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Antibodies, 1967, Cold Spring Harbor Symposia on Quantitative Biology, Volume 32, Cold Spring Harbor, New York.Google Scholar
  2. 2.
    Cohen, S., and Milstein, C., 1967, Structure and biological properties of immunoglobulins, Adv. Immunol. 7:1–89.PubMedCrossRefGoogle Scholar
  3. 3.
    Potter, M., 1972, Immunoglobulin-producing tumors and myeloma proteins of mice, Physiol. Rev. 52:631–670.PubMedGoogle Scholar
  4. 4.
    Horibata, K., and Harris, A. W., 1970, Mouse myelomas and lymphomas in culture, Exp. Cell Res. 60:61–70.PubMedCrossRefGoogle Scholar
  5. 5.
    Gaily, J. A., and Edelman, G. M., 1972, The genetic control of immunoglobulin synthesis, Annu. Rev. Genet. 6:1–30.CrossRefGoogle Scholar
  6. 6.
    Pink, J. R. L., and Milstein, C., 1967, Disulphide bridges of immunoglobulin Gl heavy chains, Nature 214:939–941.CrossRefGoogle Scholar
  7. 7.
    Kabat, E. A., Wu, T. T., Bilofsky, M., Reid-Muller, M., and Perry, M., 1983, Sequences of Proteins of Immunological Interest, National Institutes of Health, Bethesda, Maryland.Google Scholar
  8. 8.
    Honjo, T., 1984, Immunoglobulin genes, Annu. Rev. Immunol. 1:499–528.CrossRefGoogle Scholar
  9. 9.
    Köhler, G., and Milstein, C., 1975, Continuous culture of fused cells secreting antibody of predefined specificity, Nature 256:495–497.PubMedCrossRefGoogle Scholar
  10. 10.
    Sanger, F., Nicklen, S., and Coulson, A. R., 1977, DNA sequencing with chain terminating inhibitors, Proc. Natl. Acad. Sci. USA 74:5463–5467.PubMedCrossRefGoogle Scholar
  11. 11.
    Hamlyn, P. H., Brownlee, G. G., Cheng, C. C., Gait, M. J., and Milstein, C., 1978, Complete sequence of constant and 3’ non-coding regions of an immunoglobulin mRNA using the dideoxynucleotide method of RNA sequencing, Cell 15:1067–1075.PubMedCrossRefGoogle Scholar
  12. 12.
    Auffray, C., and Rougeon, F., 1980, Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma RNA, Eur. J. Biochem. 107:303–314.PubMedCrossRefGoogle Scholar
  13. 13.
    Favaloro, J., Treisman, R., and Kamen, R., 1980, Meth. Enzymol. 65:718–729.PubMedCrossRefGoogle Scholar
  14. 14.
    Berger, S. L., and Birkenmeier, C. S., 1979, Inhibition of intractable nucleases with ribonu-cleoside-vanadyl complexes: Isolation of mRNA from resting lymphocytes, Biochemistry 18:5144–5149.CrossRefGoogle Scholar
  15. 15.
    Williams, J. G., (ed.), 1981, Genetic Engineering, Volume 1, Academic Press, New York.Google Scholar
  16. 16.
    Buell, G. N., Wickens, M. P., Payvar, F., and Schimke, R. T., 1978, Full length cDNA synthesis from hen oviduct mRNAs, J. Biol. Chem. 253:2471–2482.PubMedGoogle Scholar
  17. 17.
    Retzel, E. F., Collet, M. S., and Farus, A. J., 1980, Enzymatic synthesis of deoxyribonucleic acid by avian reverse transcriptase in vitro: Optimum conditions required for transcription of large ribonucleic acid templates, Biochemistry 19:513–518.PubMedCrossRefGoogle Scholar
  18. 18.
    Kaartinen, M., Griffiths, G. M., Hamlyn, P. H., Markham, A. F., Karjalainen, K., Pelkonen, J. L. T., Mäkelä, O., and Milstein, C., 1983, Antioxazolone light and heavy chain mRNA sequences, J. Immunol. 130:937–945.PubMedGoogle Scholar
  19. 19.
    Mäkelä, O., Kaartinen, M., Pelkonen, J. L. T., and Karjalainen, K., 1978, Inheritance of antibody specificity V. Anti-2-phenyl oxazolone in the mouse, J. Exp. Med. 198:1644.Google Scholar
  20. 20.
    Kaartinen, M., Griffiths, G. M., Markham, A. F., and Milstein, C., 1983, mRNA sequences define an unusually restricted IgG response to 2 phenyl-oxazolone and its early diversification, Nature 304:320–324.PubMedCrossRefGoogle Scholar
  21. 21.
    Griffiths, G. M., Berek, C., Kaartinen, M., and Milstein, C., 1984, Somatic mutation and the maturation of the immune response to 2-phenyl oxazolone, Nature 312:271–275.PubMedCrossRefGoogle Scholar
  22. 22.
    Berek, C., Griffiths, G. M., and Milstein, C., 1985, Manuscript in preparation.Google Scholar
  23. 23.
    Sakano, H., Maki, R., Kurosawa, Y., Roeder, W., and Tonegawa, S., 1980, Two types of somatic recombinations are necessary for the generation of immunoglobulin gene recombination, Nature 286:670–683.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Gillian M. Griffiths
    • 1
  • Cesar Milstein
    • 1
  1. 1.Laboratory of Molecular BiologyMedical Research CouncilCambridgeEngland

Personalised recommendations